These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37609317)

  • 61. Molecular Defects in Cardiac Myofilament Ca
    Sheehan A; Messer AE; Papadaki M; Choudhry A; Kren V; Biedermann D; Blagg B; Khandelwal A; Marston SB
    Front Physiol; 2018; 9():243. PubMed ID: 29636697
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [A novel missense mutation, K124N, in the troponin T gene of Chinese populations with hypertrophic cardiomyopathy].
    An FS; Zhang Y; Li DQ; Yang XS; Li L; Zhang C; Yan ML; Wang Y; An GP
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1340-3. PubMed ID: 15387941
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy: a meta-analysis on 7675 individuals.
    Sedaghat-Hamedani F; Kayvanpour E; Tugrul OF; Lai A; Amr A; Haas J; Proctor T; Ehlermann P; Jensen K; Katus HA; Meder B
    Clin Res Cardiol; 2018 Jan; 107(1):30-41. PubMed ID: 28840316
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diltiazem prevents stress-induced contractile deficits in cardiomyocytes, but does not reverse the cardiomyopathy phenotype in Mybpc3-knock-in mice.
    Flenner F; Geertz B; Reischmann-Düsener S; Weinberger F; Eschenhagen T; Carrier L; Friedrich FW
    J Physiol; 2017 Jun; 595(12):3987-3999. PubMed ID: 28090637
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A rapid protocol for cardiac troponin T gene mutation detection in familial hypertrophic cardiomyopathy.
    Gerull B; Osterziel KJ; Witt C; Dietz R; Thierfelder L
    Hum Mutat; 1998; 11(2):179-82. PubMed ID: 9482583
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
    Curila K; Benesova L; Penicka M; Minarik M; Zemanek D; Veselka J; Widimsky P; Gregor P
    Genet Test Mol Biomarkers; 2009 Oct; 13(5):647-50. PubMed ID: 19645627
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Joint regulation of Wnt and bone morphogenetic protein signaling pathways to promote differentiation of human induced pluripotent stem cells into cardiomyocytes].
    Yan Y; Liu F; Hou X; Wan J; Xiong Q; Zhou R; Liao B
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2020 Oct; 34(10):1313-1321. PubMed ID: 33063499
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Abnormal blood pressure response to exercise occurs more frequently in hypertrophic cardiomyopathy patients with the R92W troponin T mutation than in those with myosin mutations.
    Heradien M; Revera M; van der Merwe L; Goosen A; Corfield VA; Brink PA; Mayosi BM; Moolman-Smook JC
    Heart Rhythm; 2009 Nov; 6(11 Suppl):S18-24. PubMed ID: 19880069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myofilament protein dynamics modulate EAD formation in human hypertrophic cardiomyopathy.
    Zile MA; Trayanova NA
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):418-428. PubMed ID: 28648627
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Wnt Signaling Interactor WTIP (Wilms Tumor Interacting Protein) Underlies Novel Mechanism for Cardiac Hypertrophy.
    De Jong HN; Dewey FE; Cordero P; Victorio RA; Kirillova A; Huang Y; Madhvani R; Seo K; Werdich AA; Lan F; Orcholski M; Liu WR; Erbilgin A; Wheeler MT; Chen R; Pan S; Kim YM; Bommakanti K; Marcou CA; Bos JM; Haddad F; Ackerman M; Vasan RS; MacRae C; Wu JC; de Jesus Perez V; Snyder M; Parikh VN; Ashley EA
    Circ Genom Precis Med; 2022 Aug; 15(4):e003563. PubMed ID: 35671065
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Micromechanical thermal assays of Ca2+-regulated thin-filament function and modulation by hypertrophic cardiomyopathy mutants of human cardiac troponin.
    Brunet NM; Mihajlović G; Aledealat K; Wang F; Xiong P; von Molnár S; Chase PB
    J Biomed Biotechnol; 2012; 2012():657523. PubMed ID: 22500102
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long-term outcomes in hypertrophic cardiomyopathy caused by mutations in the cardiac troponin T gene.
    Pasquale F; Syrris P; Kaski JP; Mogensen J; McKenna WJ; Elliott P
    Circ Cardiovasc Genet; 2012 Feb; 5(1):10-7. PubMed ID: 22144547
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Familial Hypertrophic Cardiomyopathy - Identification of cause and risk stratification through exome sequencing.
    Biswas A; Das S; Kapoor M; Shamsudheen KV; Jayarajan R; Verma A; Seth S; Bhargava B; Scaria V; Sivasubbu S; Rao VR
    Gene; 2018 Jun; 660():151-156. PubMed ID: 29572196
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment.
    Wang K; Schriver BJ; Aschar-Sobbi R; Yi AY; Feric NT; Graziano MP
    Front Bioeng Biotechnol; 2023; 11():1227184. PubMed ID: 37771571
    [No Abstract]   [Full Text] [Related]  

  • 76. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
    O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
    J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Transcriptome Analysis of Cardiac Hypertrophic Growth in
    Farrell E; Armstrong AE; Grimes AC; Naya FJ; de Lange WJ; Ralphe JC
    Front Physiol; 2018; 9():1442. PubMed ID: 30410445
    [No Abstract]   [Full Text] [Related]  

  • 78. Long-term follow-up of R403WMYH7 and R92WTNNT2 HCM families: mutations determine left ventricular dimensions but not wall thickness during disease progression.
    Revera M; Van der Merwe L; Heradien M; Goosen A; Corfield VA; Brink PA; Moolman-Smook JC
    Cardiovasc J Afr; 2007; 18(3):146-53. PubMed ID: 17612745
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy.
    Yanaga F; Morimoto S; Ohtsuki I
    J Biol Chem; 1999 Mar; 274(13):8806-12. PubMed ID: 10085122
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical and Prognostic Profiles of Cardiomyopathies Caused by Mutations in the Troponin T Gene.
    Ripoll-Vera T; Gámez JM; Govea N; Gómez Y; Núñez J; Socías L; Escandell Á; Rosell J
    Rev Esp Cardiol (Engl Ed); 2016 Feb; 69(2):149-58. PubMed ID: 26507537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.